Hager Investment Management Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.9K Sell
602
-82
-12% -$3.52K 0.01% 181
2026
Q1
$25.1K Hold
684
0.01% 179
2025
Q4
$34.8K Buy
684
+154
+29% +$7.88K 0.02% 156
2025
Q3
$29.4K Hold
530
0.02% 169
2025
Q2
$36.6K Hold
530
0.02% 152
2025
Q1
$36.8K Hold
530
0.03% 147
2024
Q4
$45.6K Buy
+530
New +$57.3K 0.03% 137

Other funds holding NVO

Hager Investment Management Services's NVO Position: Q2 2026 in Review

Hager Investment Management Services reduced its Novo Nordisk (NVO) stake by 12% in Q2 2026, selling an estimated $3.52K and leaving 602 shares worth $28.9K. The position accounts for 0.01% of the portfolio, ranked #181.

Hager Investment Management Services first reported a position in NVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $45.6K in Q4 2024. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Hager Investment Management Services held 602 shares of Novo Nordisk worth $28.9K as of Q2 2026.
  • Hager Investment Management Services sold 82 Novo Nordisk shares in Q2 2026, an estimated $3.52K.
  • Novo Nordisk made up 0.01% of Hager Investment Management Services's portfolio in Q2 2026, its #181 holding.
  • Hager Investment Management Services first reported a position in Novo Nordisk in Q4 2024 and has held it in 7 quarters since.
  • Hager Investment Management Services's Novo Nordisk position peaked at $45.6K in Q4 2024.
  • 387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Hager Investment Management Services's 13F filing for Q2 2026, filed 20 Jul 2026.